Clinical Trial Update: Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma [Phase 3]

View source ↗

Summary

A Phase 3 trial for localized high-risk rhabdomyosarcoma and rhabdomyosarcoma-like soft tissue sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma
• Soft Tissue Sarcoma

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Soft Tissue Sarcoma | Phase 3 | Status: COMPLETED